EPIX NASDAQ
ESSA Pharma Inc.
1W: -7.5%
1M: -1.9%
3M: -5.0%
1Y: -73.6%
3Y: -9.2%
5Y: -75.2%
$0.20
Last traded 2025-10-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$23M
-14.8% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$23M
-14.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$70M
+399.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$23M | -$37M | -$35M | -$27M | -$29M |
| Depreciation & Amort. | $110K | $109K | $122K | $118K | $91K |
| Stock-Based Comp. | $8K | $9K | $8K | $5M | $7M |
| Change in Working Capital | -$1M | $2M | -$780K | $2M | -$419K |
| Other Non-Cash Items | $224K | -$35K | -$831K | -$664K | -$384K |
| Operating Cash Flow | -$17M | -$25M | -$29M | -$20M | -$23M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$22M | -$57M | -$296M | -$365M | -$39M |
| Investment Sales | $0 | $22M | $243M | $362M | $131M |
| Other Investing | $274K | -$35K | $705K | $0 | $0 |
| Investing Cash Flow | -$22M | -$35M | -$52M | -$4M | $92M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4M | -$100K | -$134K | -$137K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$3M | -$8M | $387K | $69K | $0 |
| Financing Cash Flow | $42M | $142M | $253K | -$68K | $926K |
| Net Change in Cash | $3M | $82M | -$81M | -$23M | $70M |
| Cash End of Period | $56M | $138M | $57M | $34M | $104M |
| Free Cash Flow | -$17M | -$25M | -$29M | -$20M | -$23M |